Skip to Content
Merck
CN
  • Analysis of new potential anticonvulsant compounds in mice brain tissue by SPE/HPLC/DAD.

Analysis of new potential anticonvulsant compounds in mice brain tissue by SPE/HPLC/DAD.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2012-11-17)
Jolanta Flieger, Magdalena Pizoń, Tomasz Plech, Jarogniew J Luszczki
ABSTRACT

This paper describes a novel reversed-phase high performance liquid chromatography (RP-HPLC) with photo-diode array detection (DAD) method for the determination of three new derivatives of 4-alkyl-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione with different antiepileptic activity in the brains of mice treated with the doses of 300mgkg(-1) of body weight. Samples were prepared by solid-phase extraction (SPE) method using BAKERBOND™ spe Octadecyl (C(18)) and analyzed by the use of an isocratic elution mode over an Zorbax Extend-C18 column (150mm×4.6mm I.D., 5-μm, Agilent Technologies). The mobile phase consisted of 80% methanol (for compound TP-315) and 85% acetonitrile (for compound TP-321) for 80% 2-propanol (for TP-323) at a flow rate of 1.0mLmin(-1) and 0.5mLmin(-1) in the last case. Gradient elution mode was also proposed for all examined analytes in mixture with common antiepileptic drugs: carbamazepine, phenobarbital and phenytoin in view of possible synergistic activity. Photodiode-array investigations of the peaks after degradation studies indicate the stability of the compounds under conditions proposed for sample preparation procedure. Linear coefficients of correlation (r(2)) were >0.995 for all analytes. The proposed strategy gives extraction yields higher than 95% with the intra- and inter-day relative standard deviation lower than 3% and 5%, respectively. This method was applied to the analysis of brain tissue of mice treated with investigated compounds. Obtained results enable to explain the differences in their pharmacological activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,2,4-Triazole, 98%